Glispo PM 1mg/500mg/15mg Tablet SR
Marketer
Wells Biosciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glispo PM 1mg/500mg/15mg Tablet SR
Combiflor SR tablets (1mg/500mg/15mg) effectively manage blood glucose in adults with type 2 diabetes. This combination medication, used alongside diet and exercise, enhances insulin utilization, thus reducing blood sugar. Dosage and frequency should strictly follow your physician's instructions; take with food to prevent digestive discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double the dose. Excessive dosage can cause hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals raises the hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Pre-existing kidney, liver, or heart conditions, pregnancy, or breastfeeding should be disclosed to your doctor before commencing treatment. Kidney function tests will be conducted prior to prescription. Limit alcohol consumption to minimize potential side effects.
Primary Ingredients of Glispo PM 1mg/500mg/15mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Glispo PM 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glispo PM 1mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; do not chew, crush, or divide it. The Glispo PM 1mg/500mg/15mg extended-release tablet should be administered with food.
Common Side effects of Glispo PM 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glispo PM 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glispo PM 1mg/500mg/15mg SR tablet whole; do not chew, crush, or divide it. Administer this medication with food.
How Glispo PM 1mg/500mg/15mg Tablet SR works:
Glispo PM 1mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-drug approach enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further boosts insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glispo PM 1mg/500mg/15mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glispo PM 1mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks before prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glispo PM 1mg/500mg/15mg tablet is likely not safe for use while breastfeeding. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glispo PM 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. Glispo PM 1mg/500mg/15mg SR tablets are contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glispo PM 1mg/500mg/15mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. The use of Glispo PM 1mg/500mg/15mg Tablet SR is contraindicated in those with severe hepatic dysfunction.
What if you forget to take Glispo PM 1mg/500mg/15mg Tablet SR :
Should you forget a Glispo PM 1mg/500mg/15mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glispo PM 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently